These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 12548087)

  • 1. Effects of dual angiotensin-converting enzyme and neutral endopeptidase 24-11 chronic inhibition by mixanpril on insulin sensitivity in lean and obese Zucker rats.
    Arbin V; Claperon N; Fournié-Zaluski MC; Roques BP; Peyroux J
    J Cardiovasc Pharmacol; 2003 Feb; 41(2):254-64. PubMed ID: 12548087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute effect of the dual angiotensin-converting enzyme and neutral endopeptidase 24-11 inhibitor mixanpril on insulin sensitivity in obese Zucker rat.
    Arbin V; Claperon N; Fournié-Zaluski MC; Roques BP; Peyroux J
    Br J Pharmacol; 2001 Jun; 133(4):495-502. PubMed ID: 11399666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions of captopril and verapamil on glucose tolerance and insulin action in an animal model of insulin resistance.
    Dal Ponte DB; Fogt DL; Jacob S; Henriksen EJ
    Metabolism; 1998 Aug; 47(8):982-7. PubMed ID: 9711996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic effects of acute and chronic treatment with aladotril, a mixed inhibitor of neutral endopeptidase and angiotensin I-converting enzyme, in conscious rats with myocardial infarction.
    Marie C; Mossiat C; Lecomte JM; Schwartz JC; Bralet J
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1324-31. PubMed ID: 8531099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual inhibition of neutral endopeptidase and angiotensin-converting enzyme in rats with hypertension and diabetes mellitus.
    Tikkanen T; Tikkanen I; Rockell MD; Allen TJ; Johnston CI; Cooper ME; Burrell LM
    Hypertension; 1998 Oct; 32(4):778-85. PubMed ID: 9774379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual inhibition of angiotensin-converting enzyme and neutral endopeptidase by the orally active inhibitor mixanpril: a potential therapeutic approach in hypertension.
    Fournié-Zaluski MC; Gonzalez W; Turcaud S; Pham I; Roques BP; Michel JB
    Proc Natl Acad Sci U S A; 1994 Apr; 91(9):4072-6. PubMed ID: 8171037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New dual inhibitors of neutral endopeptidase and angiotensin-converting enzyme: rational design, bioavailability, and pharmacological responses in experimental hypertension.
    Fournié-Zaluski MC; Coric P; Turcaud S; Rousselet N; Gonzalez W; Barbe B; Pham I; Jullian N; Michel JB; Roques BP
    J Med Chem; 1994 Apr; 37(8):1070-83. PubMed ID: 8164250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of acute angiotensin-converting enzyme and neutral endopeptidase 24.11 inhibition on plasma extravasation in the rat.
    Sulpizio AC; Pullen MA; Edwards RM; Brooks DP
    J Pharmacol Exp Ther; 2004 Jun; 309(3):1141-7. PubMed ID: 14769834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of combined neutral endopeptidase 24-11 and angiotensin-converting enzyme inhibition on femoral vascular conductance in streptozotocin-induced diabetic rats.
    Arbin V; Claperon N; Fournié-Zaluski MC; Roques BP; Peyroux J
    Br J Pharmacol; 2000 Jul; 130(6):1297-304. PubMed ID: 10903969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin-(1-7) contributes to insulin-sensitizing effects of angiotensin-converting enzyme inhibition in obese mice.
    Loloi J; Miller AJ; Bingaman SS; Silberman Y; Arnold AC
    Am J Physiol Endocrinol Metab; 2018 Dec; 315(6):E1204-E1211. PubMed ID: 30300010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular hypertrophy in diabetic spontaneously hypertensive rats: optimizing blockade of the renin-angiotensin system.
    Lassila M; Davis BJ; Allen TJ; Burrell LM; Cooper ME; Cao Z
    Clin Sci (Lond); 2003 Apr; 104(4):341-7. PubMed ID: 12653675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular effects of captopril and enalapril in obese Zucker rats.
    Duarte J; Martinez A; Bermejo A; Vera B; Gámez MJ; Cabo P; Zarzuelo A
    Eur J Pharmacol; 1999 Jan; 365(2-3):225-32. PubMed ID: 9988106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of an angiotensin-converting enzyme inhibitor and an angiotensin II receptor antagonist on insulin resistance in fructose-fed rats.
    Higashiura K; Ura N; Takada T; Li Y; Torii T; Togashi N; Takada M; Takizawa H; Shimamoto K
    Am J Hypertens; 2000 Mar; 13(3):290-7. PubMed ID: 10777034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of in vivo activity of neutral endopeptidase 3.4.24.11 and angiotensin converting enzyme inhibitors.
    Seymour AA; Asaad MM; Abboa-Offei BE; Smith PL; Rogers WL; Dorso CR
    J Pharmacol Exp Ther; 1996 Feb; 276(2):708-13. PubMed ID: 8632340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Marked difference between angiotensin-converting enzyme and neutral endopeptidase inhibition in vivo by a dual inhibitor of both enzymes.
    Anastasopoulos F; Leung R; Kladis A; James GM; Briscoe TA; Gorski TP; Campbell DJ
    J Pharmacol Exp Ther; 1998 Mar; 284(3):799-805. PubMed ID: 9495836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of inhibition of angiotensin converting enzyme and/or neutral endopeptidase on vascular and neural complications in high fat fed/low dose streptozotocin-diabetic rats.
    Davidson EP; Coppey LJ; Holmes A; Yorek MA
    Eur J Pharmacol; 2012 Feb; 677(1-3):180-7. PubMed ID: 22198047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasopeptidase inhibitor omapatrilat induces profound insulin sensitization and increases myocardial glucose uptake in Zucker fatty rats: Studies comparing a vasopeptidase inhibitor, angiotensin-converting enzyme inhibitor, and angiotensin II type I receptor blocker.
    Wang CH; Leung N; Lapointe N; Szeto L; Uffelman KD; Giacca A; Rouleau JL; Lewis GF
    Circulation; 2003 Apr; 107(14):1923-9. PubMed ID: 12668518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual inhibition of angiotensin converting enzyme and neutral endopeptidase by omapatrilat in rat in vivo.
    Bäcklund T; Palojoki E; Grönholm T; Eriksson A; Vuolteenaho O; Laine M; Tikkanen I
    Pharmacol Res; 2001 Nov; 44(5):411-8. PubMed ID: 11712872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of alatriopril, a mixed inhibitor of atriopeptidase and angiotensin I-converting enzyme, on cardiac hypertrophy and hormonal responses in rats with myocardial infarction. Comparison with captopril.
    Bralet J; Marie C; Mossiat C; Lecomte JM; Gros C; Schwartz JC
    J Pharmacol Exp Ther; 1994 Jul; 270(1):8-14. PubMed ID: 8035346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiorenal consequences of dual angiotensin converting enzyme and neutral endopeptidase 24.11 inhibition in transgenic rats with an extra renin gene.
    Wegner M; Hirth-Dietrich C; Knorr A; Dressel J; Ganten D; Stasch JP
    Hypertens Res; 1996 Sep; 19(3):151-9. PubMed ID: 8891743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.